Generation Bio Co. (GBIO)

Compare

0.3975

+0.0273

+(7.37%)

At close: April 3 at 4:00:01 PM EDT

Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference

CAMBRIDGE, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will participate in a fireside chat at the 24th Annual Needham Virtual Healthcare Conference on Wednesday, April 9th at 12:45 p.m. ET. A live webcast of the presentation will be available on the investor section of the c

GlobeNewswire yesterday

GBIO
+7.37%
Generation Bio Co. (GBIO) Reports Q4 Loss, Tops Revenue Estimates

Generation Bio (GBIO) delivered earnings and revenue surprises of -14.29% and 6.95%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 21 days ago

GBIO
+7.37%
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results

- Company is applying its T cell-selective lipid nanoparticle to develop siRNA therapeutics for T cell-driven autoimmune diseases - Lead target and indication to be announced MY 2025 - Cash balance of $185.2 million expected to fund operations into 2H 2027 CAMBRIDGE, MASS., March 13, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, reported business highlights and fourth

GlobeNewswire 21 days ago

GBIO
+7.37%
Generation Bio to Present at the TD Cowen 45th Annual Health Care Conference

CAMBRIDGE, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will present at the TD Cowen 45th Annual Health Care Conference on Monday, March 3, 2025 at 9:10 a.m. ET in Boston. A live webcast of the presentation will be available on the investor section of the company’s website at

GlobeNewswire last month

GBIO
+7.37%
3 US Penny Stocks With Market Cap Under $70M

As the S&P 500 edges toward new highs amidst mixed trading sessions, investors are paying close attention to smaller market segments for potential opportunities. Penny stocks, though an older term, continue to represent a compelling area of interest due to their association with smaller or emerging companies that might offer significant growth potential. By focusing on those with strong financials and solid fundamentals, investors can find unique opportunities in this often-overlooked segment...

Simply Wall St. 2 months ago

GBIO
+7.37%
GRCE
Will Generation Bio (NASDAQ:GBIO) Spend Its Cash Wisely?

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Simply Wall St. 2 months ago

GBIO
+7.37%
Generation Bio Independent Director Acquires 131% More Stock

Potential Generation Bio Co. ( NASDAQ:GBIO ) shareholders may wish to note that the Independent Director, Anthony...

Simply Wall St. 2 months ago

GBIO
+7.37%
Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases

Novel programs will combine validated cell-targeted LNP (ctLNP) delivery with siRNA to selectively modulate T cells in vivoPrograms to focus on silencing hard-to-drug targets of high therapeutic value in T cell-driven autoimmune diseasesCompany reorganization supports evolution of ctLNP-enabled strategy and buildout of clinical capabilities ahead of first IND expected in 2H 2026 CAMBRIDGE, Mass., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company working t

GlobeNewswire 2 months ago

GBIO
+7.37%
US Penny Stocks Spotlight: LiveOne And 2 Other Promising Picks

As the U.S. stock market continues to reach new heights, with the S&P 500 and Nasdaq hitting record levels driven by gains in technology stocks, investors are increasingly exploring diverse opportunities across different sectors. Penny stocks, though often considered a relic of past market eras, remain an intriguing area for those looking to uncover growth potential at lower price points. These smaller or newer companies can offer significant value when they possess strong balance sheets and...

Simply Wall St. 3 months ago

GBIO
+7.37%
RLMD

LVO
Earnings Update: Generation Bio Co. (NASDAQ:GBIO) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Generation Bio Co. ( NASDAQ:GBIO ) just released its third-quarter report and things are looking bullish. Results...

Simply Wall St. 4 months ago

GBIO
+7.37%
Generation Bio Third Quarter 2024 Earnings: Beats Expectations

Generation Bio ( NASDAQ:GBIO ) Third Quarter 2024 Results Key Financial Results Revenue: US$7.55m (up 252% from 3Q...

Simply Wall St. 4 months ago

GBIO
+7.37%
Generation Bio Co. (GBIO) Reports Q3 Loss, Tops Revenue Estimates

Generation Bio (GBIO) delivered earnings and revenue surprises of 17.86% and 249.24%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 4 months ago

GBIO
+7.37%
Generation Bio Reports Recent Business Highlights and Third Quarter 2024 Financial Results

Non-human primate data presented at ESGCT demonstrated selective in vivo delivery of mRNA with T cell-targeted lipid nanoparticle (ctLNP) Cash balance of $199.8 million expected to fund operations into 2H 2027 CAMBRIDGE, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, reported business highlights and third quarter 2024 financial results. “There is immense potential

GlobeNewswire 4 months ago

GBIO
+7.37%
Promising Penny Stocks On US Exchanges In November 2024

As October 2024 came to a close, major U.S. indices like the S&P 500, Nasdaq, and Dow Jones Industrial Average posted losses for the month, driven by disappointing earnings from big tech companies. In light of these market fluctuations, investors may find opportunities in lesser-known areas such as penny stocks—stocks often associated with smaller or newer companies that can still offer surprising value despite their outdated moniker. By focusing on those with solid financial foundations and...

Simply Wall St. 4 months ago

GBIO
+7.37%
OSUR

CDXS
Bullish Generation Bio Insiders Loaded Up On US$778.9k Of Stock

Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...

Simply Wall St. 5 months ago

GBIO
+7.37%
Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual Congress

New non-human primate data show highly selective in vivo delivery of mRNA to T cells with a cell-targeted lipid nanoparticle (ctLNP) CAMBRIDGE, Mass., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today presented data on its cell-targeted lipid nanoparticle (ctLNP) and immune-quiet DNA (iqDNA) platforms at the European Society of Gene and Cell Therapy (ESGCT) 31st Annual

GlobeNewswire 5 months ago

GBIO
+7.37%
Generation Bio to Present at the 2024 Cantor Global Healthcare Conference

CAMBRIDGE, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will participate in a fireside chat at the 2024 Cantor Global Healthcare Conference on Thursday, September 19, 2024 at 10:20 a.m. ET in New York. A live webcast of the presentation will be available on the investor section of the co

GlobeNewswire 6 months ago

GBIO
+7.37%
Generation Bio Co. (NASDAQ:GBIO) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates

One of the biggest stories of last week was how Generation Bio Co. ( NASDAQ:GBIO ) shares plunged 21% in the week since...

Simply Wall St. 7 months ago

GBIO
+7.37%
Generation Bio Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Generation Bio ( NASDAQ:GBIO ) Second Quarter 2024 Results Key Financial Results Revenue: US$4.09m (up 365% from 2Q...

Simply Wall St. 7 months ago

GBIO
+7.37%
Generation Bio Co. (GBIO) Reports Q2 Loss, Tops Revenue Estimates

Generation Bio (GBIO) delivered earnings and revenue surprises of -14.81% and 26.85%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 7 months ago

GBIO
+7.37%

Performance Overview

Return	GBIO	S&P 500 (^GSPC)
YTD	-62.50%	-8.25%
1-Year	-90.35%	+3.55%
3-Year	-95.14%	+18.71%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Generation Bio Co. (GBIO)

Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference

Generation Bio Co. (GBIO) Reports Q4 Loss, Tops Revenue Estimates

Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results

Generation Bio to Present at the TD Cowen 45th Annual Health Care Conference

3 US Penny Stocks With Market Cap Under $70M

Will Generation Bio (NASDAQ:GBIO) Spend Its Cash Wisely?

Generation Bio Independent Director Acquires 131% More Stock

Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases

US Penny Stocks Spotlight: LiveOne And 2 Other Promising Picks

Earnings Update: Generation Bio Co. (NASDAQ:GBIO) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Generation Bio Third Quarter 2024 Earnings: Beats Expectations

Generation Bio Co. (GBIO) Reports Q3 Loss, Tops Revenue Estimates

Generation Bio Reports Recent Business Highlights and Third Quarter 2024 Financial Results

Promising Penny Stocks On US Exchanges In November 2024

Bullish Generation Bio Insiders Loaded Up On US$778.9k Of Stock

Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual Congress

Generation Bio to Present at the 2024 Cantor Global Healthcare Conference

Generation Bio Co. (NASDAQ:GBIO) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates

Generation Bio Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Generation Bio Co. (GBIO) Reports Q2 Loss, Tops Revenue Estimates

Performance Overview